RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sudha Sharma to Ligands

This is a "connection" page, showing publications Sudha Sharma has written about Ligands.
Connection Strength

0.085
  1. Dhanjal JK, Nigam N, Sharma S, Chaudhary A, Kaul SC, Grover A, Wadhwa R. Embelin inhibits TNF-a converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence. BMC Cancer. 2014 Oct 22; 14:775.
    View in: PubMed
    Score: 0.025
  2. Dhanjal JK, Goyal S, Sharma S, Hamid R, Grover A. Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer's plaque pathology. Biochem Biophys Res Commun. 2014 Jan 17; 443(3):1054-9.
    View in: PubMed
    Score: 0.024
  3. Dhiman H, Dhanjal JK, Sharma S, Chacko S, Grover S, Grover A. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B. Biochem Biophys Res Commun. 2013 Apr 19; 433(4):552-7.
    View in: PubMed
    Score: 0.023
  4. Doherty KM, Sharma S, Gupta R, Brosh RM. Tetraplex binding molecules as anti-cancer agents. Recent Pat Anticancer Drug Discov. 2006 Jun; 1(2):185-200.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support